Engineering and material considerations in islet cell transplantation

Annual Review of Biomedical Engineering

Volumn , Issue 1, 1999, Pages 103-127

  Chaikof, Elliot L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Artificial organs; Biomaterials; Diabetes; Immunoisolation; Semipermeable membranes

Indexed keywords

BIOMATERIAL;

ANIMAL; BIOMEDICAL ENGINEERING; HUMAN; IMMUNOLOGY; METHODOLOGY; PANCREAS ISLET TRANSPLANTATION; PHYSIOLOGY; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMEDICAL ENGINEERING; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TISSUE ENGINEERING;

EID: 0033302716     PISSN: 15239829     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.bioeng.1.1.103     Document Type: Article

References (4)

1. Aebischer P, Buchser E, Joseph JM, Favre J, de Tribolet N, et al. 1994. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression: a preliminary report. Transplantation.58:1275-77
2. Aebischer P, Schluep M, Deglon N, Joseph JM, Hirt L, et al. 1996. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med. 2:696-99
3. Alejandro R, Lehmann R, Ricordi C, Kenyon NS, Angelico MC, et al. 1997. Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes 46:1983-89
4. Algire GH, Weaver JM, Prehn RT. 1954. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immifnized mice. J. Natl. Cancer Inst. 15:493-507